Kovack Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-2,165
| Closed | -$207K | – | 581 |
|
|
2024
Q1 | $207K | Buy |
+2,165
| New | +$207K | 0.03% | 432 |
|
|
2022
Q3 | – | Sell |
-8,797
| Closed | -$837K | – | 577 |
|
|
2022
Q2 | $837K | Sell |
8,797
-1,147
| -12% | -$109K | 0.11% | 201 |
|
|
2022
Q1 | $1.17M | Sell |
9,944
-594
| -6% | -$69.9K | 0.12% | 173 |
|
|
2021
Q4 | $1.37M | Sell |
10,538
-812
| -7% | -$105K | 0.13% | 169 |
|
|
2021
Q3 | $1.29M | Buy |
11,350
+7,328
| +182% | +$830K | 0.14% | 171 |
|
|
2021
Q2 | $417K | Buy |
4,022
+703
| +21% | +$72.9K | 0.05% | 401 |
|
|
2021
Q1 | $278K | Sell |
3,319
-1,079
| -25% | -$90.4K | 0.04% | 490 |
|
|
2020
Q4 | $401K | Buy |
4,398
+967
| +28% | +$88.2K | 0.06% | 331 |
|
|
2020
Q3 | $274K | Sell |
3,431
-3,315
| -49% | -$265K | 0.05% | 345 |
|
|
2020
Q2 | $466K | Sell |
6,746
-157
| -2% | -$10.8K | 0.09% | 223 |
|
|
2020
Q1 | $434K | Buy |
6,903
+1,116
| +19% | +$70.2K | 0.1% | 211 |
|
|
2019
Q4 | $450K | Buy |
5,787
+84
| +1% | +$6.53K | 0.08% | 264 |
|
|
2019
Q3 | $418K | Buy |
5,703
+90
| +2% | +$6.6K | 0.09% | 262 |
|
|
2019
Q2 | $346K | Buy |
5,613
+414
| +8% | +$25.5K | 0.08% | 275 |
|
|
2019
Q1 | $332K | Sell |
5,199
-99
| -2% | -$6.32K | 0.08% | 270 |
|
|
2018
Q4 | $270K | Buy |
5,298
+414
| +8% | +$21.1K | 0.08% | 283 |
|
|
2018
Q3 | $283K | Sell |
4,884
-10,065
| -67% | -$583K | 0.07% | 300 |
|
|
2018
Q2 | $725K | Buy |
14,949
+2,328
| +18% | +$113K | 0.2% | 127 |
|
|
2018
Q1 | $587K | Buy |
12,621
+6,819
| +118% | +$317K | 0.15% | 162 |
|
|
2017
Q4 | $218K | Buy |
+5,802
| New | +$218K | 0.06% | 389 |
|